NCT00217737 2026-03-18
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Ipsen
Yale University
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
Seagen Inc.
Baylor College of Medicine